Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma

Stopped no patients were enrolled

Conditions

• Melanoma

Interventions

• DRUG: Cobimetinib
• DRUG: Vemurafenib

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

• [object Object]